Triple-negative breast cancer (TNBC) is a subtype of breast cancer in which the estrogen receptor and progesterone receptor are not expressed, and human epidermal growth factor鈥搑eceptor 2 is not amplified or o
Triple-negative breast cancer (TNBC) is highly aggressive, difficult to treat and commonly develops visceral metastasis, including lung metastasis. We observed that High mobility group box 1 protein (HMGB1) was highly expressed in human TNBC and positively correlated with cancer metastasis. The hypoxic...
Triple-negative breast cancer (TNBC) is a biologically and clinically heterogeneous disease, which has long been considered to present a major unmet need due to its aggressive behaviour and poor prognosis, with chemotherapy being the only available therapeutic option1. Decades of research on TNBC hav...
三阴性乳腺癌(Triple Negative Breast Cancer, TNBC)指的是一种缺乏雌激素受体(ER)、孕激素受体(PR)和HER2受体的乳腺癌类型。这种类型的乳腺癌更具侵袭性,且缺乏激素治疗和HER2靶向治疗的靶点,因此治疗选择较为有限,传统的化疗仍是其主要治疗手段。但近年来,靶向药物和免疫疗法的不断创新为该疾病的治疗带来了新希望...
Triple-negative breast cancer (TNBC) is characterized by a lack of expression of both ER and PgR as well as HER-2. Thus, to date, chemotherapy remains the only possible therapeutic option in the adjuvant or metastatic setting in the TNBC. A recent analysis indicates that TNBC carries a dist...
Triple-negative breast cancer is a type of breast cancer in which cancer cells test negative for three of the main things that are usually found in breast cancer – the hormones estrogen and progesterone, and a protein called HER2. These receptors typically fuel breast cancer growth, and doctors...
Breast cancer is the most frequently diagnosed cancer globally and the leading cause of cancer-related deaths among women.1 Approximately 15% of breast cancers are classified as triple-negative breast cancer (TNBC). TNBC is characterized by the absence of the estrogen receptor, the progesterone ...
三阴性乳腺癌triple negative breast cancer.pdf,Triple negative breast cancer- update on classification and • Basal like breast cancer and triple negative cancer biomarkers • Heterogeneity of triple negative cancer • Further classification of trip
Also known as:Triple Negative Breast Cancer(TNBC)/Triple-Negative Breast Cancer/ER-Negative PR-Negative HER2-Negative Breast Cancer/TNBC/Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative/Triple Negative Breast Cancer/Triple negative malignant neoplasm of breast/TNBC - ...
Breast cancer is the most frequently diagnosed cancer globally and the leading cause of cancer-related deaths among women.1Approximately 15% of breast cancers are classified as triple-negative breast cancer (TNBC). TNBC is characterized by the absence of the estrogen receptor, the progest...